Legend Biotech Corporation(NASDAQ:LEGN) 
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in North America and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen re...
Website: https://legendbiotech.com/
Founded: 2014
Full Time Employees: 800
CEO: Yuan Xu
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 31.97
H 32.37
L 30.89
C 32.01
V 1,458,092
10EMA 32.01
20EMA 32.01
60EMA 32.01
120EMA 32.01
250EMA 32.01